Skip to main content
U.S. flag

An official website of the United States government

NIA Funding Line Policy for FY 2023

Update (3/31/2023): The information below reflects an update to the NIA funding policy for fiscal year (FY) 2023 in both the General Allocation and Alzheimer's Allocation categories.

NIA and NIH received an appropriation through the H.R.2617, the Consolidated Appropriations Act, 2023 which provides full-year funding through September 30, 2023.

NIA will now pay FY 2022 non-competing awards at 100% of the committed level as shown in the Notice of Award.

General Allocation

NIA is now reducing FY 2023 competing awards by 16% on average; this is a 2% reduction in cuts, meaning a 2% increase in funds awarded in comparison with our previous funding policy. This average cut policy applies to all research project awards except R03s (small grants), R21s (exploratory/developmental awards) and R15s (Academic Research Enhancement Awards and the NIH Research Enhancement Awards program). These awards (R03, R21, R15) generally receive the study-section-recommended amount of support. Additionally, all Early Stage Investigators (ESIs) and New Investigators (NIs) applications will not receive the reduction and will receive the study-section-recommended amount of support.

Note: The 16% cut remains an average. Individual awards may be reduced by more or less than that percentage. All previously awarded FY 2023 competing awards will be adjusted to reflect the new policy.

Alzheimer’s Allocation

NIA is paying awards at their full study section-recommended amounts, unless concerns about overlap or similar issues reduce the amount awarded.

Pay lines

CSR-reviewed Research Applications (Percentile Based)

Applications

General pay line, < $500k

General pay line, ≥ $500k

AD/ADRD pay line

All (except below)

15%

12%

25%

New Investigator R01s

18%

15%

28%

Early Stage Investigator R01s

20%

17%

30%

Though NIA expects to pay most applications within these lines, when scientific concerns are identified in peer review that weaken the case for making an award, we may alternatively provide short-term support (R56) or invite a re-submission of the application. Similarly, we may pay a few applications beyond the pay lines when they focus on high priorities of the institute.

NIA-reviewed Research Applications (Overall Impact Score Based)

Applications

General pay line

AD/ADRD pay line

Program projects

24

35

Other NIA-reviewed research

24

35

Parent career development awards

24

35

Parent fellowship awards

30

40

Though NIA expects to pay most applications within these lines, when scientific concerns are identified in peer review that weaken the case for making an award, we may invite a re-submission of the application. Similarly, we may pay a few applications beyond the pay lines when they focus on high priorities of the institute.

All other categories of awards (Conference, Institutional Training, Small Business) are allocation-based rather than based on a funding line.

nia.nih.gov

An official website of the National Institutes of Health